Entry Detail



General Information

Database ID:exR0012370
RNA Name:RPLP2
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):809965End Site(bp):812880
External Links:ENSG00000177600



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010646.1
chr19
17235940
17255448
-
ALDOA
chr16
30064164
30070457
+
AL139300.1
chr14
103562962
103685924
+
AC011455.2
chr19
38915404
38949855
-
AGO4
chr1
35808016
35857890
+
AKAP1
chr17
57085092
57121346
+
AC007192.1
chr19
18153158
18178117
+
AC135050.2
chr16
31083439
31094956
-
ADGRL2
chr1
81306160
81992436
+
AC010422.3
chr19
12643831
12648397
-
AC020915.5
chr19
58228914
58315183
+
AKT2
chr19
40230317
40285536
-
AFTPH
chr2
64524305
64593005
+
ACIN1
chr14
23058564
23095614
-
AIFM1
chrX
130129362
130165887
-
AC004922.1
chr7
99325879
99394653
+
AL049629.2
chr11
33698261
33722467
-
ADCY1
chr7
45574140
45723116
+
ACTG1
chr17
81509971
81523847
-
AFDN
chr6
167826922
167972023
+
AC005258.1
chr19
2269525
2341172
+
ADRM1
chr20
62302093
62308862
+
AL121594.1
chr14
35122549
35317474
+
ALDH18A1
chr10
95605941
95656711
-
AGRN
chr1
1020120
1056118
+
ADH5
chr4
99070978
99088801
-
AACS
chr12
125065434
125143333
+
AGBL5
chr2
27042364
27070622
+
ABCF1
chr6
30571393
30597179
+
AC008878.3
chr19
7382834
7470241
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-7705
chr8
100703002
100703024
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007780.1
chr17
68413623
68524949
+
AC017104.1
chr2
231388976
231394991
+
AC018521.1
chr17
47945424
47981736
+
AC026362.1
chr12
122975320
122982907
+
AD000090.1
chr19
35557956
35581954
+
AL137782.1
chr13
75549773
75807120
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.